<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5510">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04800861</url>
  </required_header>
  <id_info>
    <org_study_id>1121</org_study_id>
    <nct_id>NCT04800861</nct_id>
  </id_info>
  <brief_title>Glycemic Control in Diabetic Hospitalized Patients</brief_title>
  <official_title>Glycemic Control in Diabetic Hospitalized Patients: a Cross Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AlFayhaa General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AlFayhaa General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the advanced management of diabetes and new innovative anti-hyperglycemic therapy&#xD;
      hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the&#xD;
      hospital in general wards. Efforts from health care providers to assess and control blood&#xD;
      sugar by a simplified method such as certified point of care hand-sized glucometers is the&#xD;
      fruitful protocol if the results near the target that is endorsed by well-known diabetes&#xD;
      societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl&#xD;
      after a meal. The unstable economy and political crises with the pandemic of Covid-19 making&#xD;
      us use a glucometer to monitor and control the fluctuation of blood sugar in order to&#xD;
      decrease the burden on the patients and health care providers in the form of a stay in the&#xD;
      hospital and minimize wasting laboratory resources.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>glycemic control</measure>
    <time_frame>From hospital admission to hospital discharge for a median of 7 days and up to 1 month</time_frame>
    <description>percentage of patients with glucose measurement (Random Blood Sugar, RBS, Fasting Blood Sugar, FBS) between 140-180 measured with bedside glucometers preferably before meals and at 6 am for fasting blood sugars or as directed by the physician</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>average blood glucose value per ward</measure>
    <time_frame>From hospital admission to hospital discharge for a median of 7 days and up to 1 month</time_frame>
    <description>average blood glucose value per ward (medical vs. surgical vs ICU/CCU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average per patient</measure>
    <time_frame>From hospital admission to hospital discharge for a median of 7 days and up to 1 month</time_frame>
    <description>average blood glucose levels per patient</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        diabetic patients admitted in the hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admitted to the hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AbdulSattar J Yousif, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Al-Fayhaa teaching hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Hussein A Alhamza, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Al-Fayhaa teaching hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alhasan M Al-Mudhaffer, BCPS</last_name>
    <phone>+9647801601693</phone>
    <email>user11126@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AlFayhaa Teaching hospital</name>
      <address>
        <city>Basra</city>
        <zip>99999</zip>
        <country>Iraq</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alhasan M Al-Mudhaffer, BCPS</last_name>
      <phone>009647801601693</phone>
      <email>user11126@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Qusay N AlMalikee, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 14, 2021</last_update_submitted>
  <last_update_submitted_qc>March 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes mellitus</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>glycemic control</keyword>
  <keyword>inpatient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>unidentified patient data will be shared if requested</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

